β-Blockers, Pneumonia, and Outcome after Ischemic Stroke

Stroke

Volumn 46, Issue 5, 2015, Pages 1269-1274

  Sykora, Marek ^a   Siarnik, Pavel ^b   Diedler, Jennifer ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Faculty of Natural Sciences   (Slovakia)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

autonomic nervous system; beta blockers, androgenic; infection; mortality; outcome assessment; pneumonia; stroke

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; NEUROPROTECTIVE AGENT;

AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; DRUG EXPOSURE; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITAL INFECTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RANKIN SCALE; TIME TO TREATMENT; TREATMENT OUTCOME; ADULT; COMPLICATION; INFORMATION CENTER; MIDDLE AGED; STROKE; VERY ELDERLY; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ARCHIVES; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PNEUMONIA; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84933528148     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.008260     Document Type: Conference Paper

References (25)

1. Barron SA, Rogovski Z, Hemli J. Autonomic consequences of cerebral hemisphere infarction. Stroke. 1994;25:113-116.
2. Mäkikallio AM, Mäkikallio TH, Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllylä VV. Heart rate dynamics predict poststroke mortality. Neurology. 2004;62:1822-1826.
3. Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology. 2001;57:833-838.
4. Sykora M, Diedler J, Turcani P, Hacke W, Steiner T. Baroreflex: a new therapeutic target in human stroke? Stroke. 2009;40:e678-e682. doi: 10.1161/STROKEAHA.109.565838.
5. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;20:1197-1204. doi: 10.1097/00004647-200008000-00005.
6. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, et al. Strokeinduced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198:725-736. doi: 10.1084/jem.20021098.
7. Laowattana S, Oppenheimer SM. Protective effects of beta-blockers in cerebrovascular disease. Neurology. 2007;68:509-514. doi: 10.1212/01. wnl.0000253186.23949.f.d.
8. Dziedzic T, Slowik A, Pera J, Szczudlik A. Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007;252:53-56. doi: 10.1016/j.jns.2006.10.007.
9. Urra X, Obach V, Chamorro A. Stroke induced immunodepression syndrome: from bench to bedside. Curr Mol Med. 2009;9:195-202.
10. Vogelgesang A, Becker KJ, Dressel A. Immunological consequences of ischemic stroke. Acta Neurol Scand. 2014;129:1-12. doi: 10.1111/ane.12165.
11. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37:2607-2612. doi: 10.1161/01.STR.0000240409.68739.2b.
12. Kalita J, Misra UK, Kumar B. Is blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage? Neurol Sci. 2013;34:1099-1104. doi: 10.1007/s10072-012-1210-y.
13. Ali M, Bath P, Brady M, Davis S, Diener HC, Donnan G, et al; VISTA Steering Committees. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke. 2012;7:133-138. doi: 10.1111/j.1747-4949.2011.00735.x.
14. Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T. Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med. 2008;36:3074-3079. doi: 10.1097/CCM.0b013e31818b306d.
15. Colivicchi F, Bassi A, Santini M, Caltagirone C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke. 2005;36:1710-1715. doi: 10.1161/01.STR.0000173400.19346.b.d.
16. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730-1737.
17. Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30:27-34.
18. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683-1691. doi: 10.1001/jama.2013.278477.
19. van der Jagt M, Miranda DR. Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome. Recent Pat Cardiovasc Drug Discov. 2012;7:141-151.
20. Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26-33, discussion 33. doi: 10.1097/TA.0b013e31802d02d0.
21. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed). 1988;296:737-741.
22. De Raedt S, Haentjens P, De Smedt A, Brouns R, Uyttenboogaart M, Luijckx GJ, et al. Pre-stroke use of beta-blockers does not affect ischaemic stroke severity and outcome. Eur J Neurol. 2012;19:234-240. doi: 10.1111/j.1468-1331.2011.03475.x.
23. Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8:401-410. doi: 10.1038/nrneurol.2012.98.
24. Haeusler KG, Schmidt WU, Föhring F, Meisel C, Helms T, Jungehulsing GJ, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis. 2008;25:50-58. doi: 10.1159/000111499.
25. Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, et al. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One. 2008;3:e2158. doi: 10.1371/journal. pone.0002158.